Back to Journals » Clinical Ophthalmology » Volume 3
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Update on thyroid eye disease and management
Authors Bothun E, Scheuer RA, Harrison A, Lee M
Published 15 October 2009 Volume 2009:3 Pages 543—551
DOI https://doi.org/10.2147/OPTH.S5228
Review by Single anonymous peer review
Peer reviewer comments 3
Erick D Bothun,1,2 Ryan A Scheurer,1 Andrew R Harrison,1,3 Michael S Lee1,4,5
1Departments of Ophthalmology, 2Pediatrics, 3Otolaryngology, 4Neurosurgery, and 5Neurology, University of Minnesota, Minneapolis, Minnesota, USA
Abstract: Thyroid eye disease is a heterogeneous autoimmune orbital reaction typically manifesting in middle age. The inflammation may parallel or remain isolated from a related inflammatory cascade in the thyroid called Graves’ disease. The orbital manifestations can lead to severe proptosis, dry eyes, strabismus, and optic neuropathy. In this article, we will discuss this unique condition including the ophthalmic findings and management.
Keywords: Graves’ disease, thyroid eye disease, proptosis, orbital decompression, enlarged extraocular muscles
© 2009 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.